Experimental drug changed runner's life, but FDA rejected it for now
Denial was a shock because the Trump administration had fast-tracked the drug. The manufacturer can still seek FDA approval with better proof that it treats painful skin disorder.
More from Minnesota Business
Star Tribune Business
War made planting difficult. Now it could boost farmers' profits.
Minnesota Business
•
9h ago
Star Tribune Business
Ramstad: Fraud in Minnesota has not cost $9 billion, but it's hurt more
Minnesota Business
•
1d ago
Star Tribune Business
Summit Brewing could avoid foreclosure with new lender
Minnesota Business
•
2d ago
Star Tribune Business
Watch the replays of the North Star Summit sessions
Minnesota Business
•
3d ago